Lytix Biopharma AS
OSL-LYTIX
NYSE
NYSE
Healthcare
Biotechnology
Global Rank
#28252
Country Rank
#177
Market Cap
58.04 M
Price
0.85
Change (%)
0.92%
Volume
38,650
Lytix Biopharma AS's latest marketcap:
58.04 M
As of 06/07/2025, Lytix Biopharma AS's market capitalization has reached $58.04 M. According to our data, Lytix Biopharma AS is the 28252th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 58.04 M |
| Revenue (ttm) | 60,112.96 |
| Net Income (ttm) | -8,799,924.35 |
| Shares Out | 68.26 M |
| EPS (ttm) | 0 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 05/15/2025 |
Market Cap Chart
Data Updated: 06/07/2025
Lytix Biopharma AS's yearly market capitalization.
Lytix Biopharma AS has seen its market value grow from kr532.66 M to kr587.05 M since 2021, representing a total increase of 10.21% and an annual compound growth rate (CAGR) of 2.87%.
| Date | Market Cap | Change (%) |
|---|---|---|
| 06/07/2025 | kr587.05 M | 47.62% |
| 12/30/2024 | kr401.38 M | 106.12% |
| 12/29/2023 | kr194.73 M | -37.37% |
| 12/30/2022 | kr310.93 M | -41.63% |
| 12/30/2021 | kr532.66 M |
Company Profile
Lytix Biopharma AS was founded in 2003 in Norway.
on the Oslo Børs.
With 8 employees, it focuses on Healthcare and aims to drive innovation in Biotechnology.
Frequently Asked Questions
-
What is Lytix Biopharma AS's (OSL-LYTIX) current market cap?As of 06/07/2025, Lytix Biopharma AS (including the parent company, if applicable) has an estimated market capitalization of $58.04 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Lytix Biopharma AS (OSL-LYTIX) rank globally by market cap?Lytix Biopharma AS global market capitalization ranking is approximately 28252 as of 06/07/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.